Keywords: Cell Therapeutics, Pixuvri, European launch, Myelofibrosis, NHL, Pacritinib, Tostedostat

Cell Therapeutics prepares for EU launch of Pixuvri

Article | 21 June 2012

USA-based biotech company Cell Therapeutics (Nasdaq and MTA: CTIC) said yesterday that it is re-aligning its resources and re-prioritizing its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Cell Therapeutics

Go to company listing

Related Drugs

Pixuvri

pacritinib

tostedostat

Go to drug listing